Methylprednisolone (oral)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Methylprednisolone (oral), covering 2012-12-05 to 2016-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse [Phase 4]